EIB loan to expand Melsungen's r&d

The European Investment Bank (EIB), the EU's lending institution, has announced a loan of Euro 125m to B. Braun Melsungen (BBM), a leading international supplier of pharmaceuticals and medical technologies to hospitals, based in Hessen, Germany.

The European Investment Bank (EIB), the EU's lending institution, has announced a loan of Euro 125m to B. Braun Melsungen (BBM), a leading international supplier of pharmaceuticals and medical technologies to hospitals, based in Hessen, Germany.

The EIB said the money would be used to expand BBM's research infrastructure and to develop innovative pharmaceutical products and production processes over the period 2008 - 2010. The expansion includes construction of a new central laboratory and pharmaceutical cleanrooms at the firm's headquarters in Melsungen, Hessen.

According to the EIB, the loan will "further strengthen BBM's position in the infusion therapy segment and upgrade the company's main production site". BBM has more than 35,000 employees worldwide, including more than 1, 000 in Germany.

Companies